Reference
  1. Heavey PM, McKenna D, Rowland IR (2004). Colorectal cancer and relationship between genes and the environment. Nutr Cancer, 48, 124-41.
  2. Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics 2002. CA Cancer J Clin, 55, 74-108.
  3. Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014 383:1490-1502.
  4. Weitz J, Koch M, Debus J, Hohler T, Galle PR et al (2005) Colorectal cancer. Lancet 365:153–165.
  5. INCA (Instituto Nacional do Câncer). [Internet]. Accessed April 9, 2015. Available at [http://www.inca.gov.br].
  6. Khan N, Afaq F, Mukhtar H. Lifestyle as risk factor for cancer: Evidence from human studies. Cancer Lett. 2010;293:133–143.
  7. Ahmed FE. Gene-gene, gene-environment & multiple interactions in colorectal cancer. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2006; 24:1–101.
  8. Tomlinson IP, Webb E, Carvajal-Carmona L, Broderick P, Howarth K, Pittman AM, Spain S, Lubbe S, Walther A, et al. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet 2008; 40: 623-630
  9. Abulí A, Bessa X, González JR, Ruiz-Ponte C, Cáceres A, Muñoz J, Gonzalo V, Balaguer F, Fernández-Rozadilla C, González D, et al. Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype. Gastroenterology 2010; 139: 788-796, 796.e1-e6
  10. Lewis DF. P450 structures and oxidative metabolism of xenobiotics. Pharmacogenomics 4: 387-395, 2003.
  11. McKay JA, Murray GI, Weaver RJ, Ewen SW, Melvin WT, Burke MD. Xenobiotic metabolising enzyme expression in colonic neoplasia. Gut 1993;34:1234–9.
  12. Hummerich J, Zohm C, Pfau W. Modulation of cytochrome P450 1A1 by food-derived heterocyclic aromatic amines. Toxicology 2004;199:231–40.
  13. Crofts F,CosmaGN,Currie D, TaioliE,Toniolo P,GarteSJ.Anovel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis. 1993;14:1729–31.
  14. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett. 1990;263:131-3.
  15. Shah, P.P., Saurabh, K., Pant, M.C., Mathur, N., Parmar, D., 2009. Evidence for increased cytochrome P450 1A1 expression in blood lymphocytes of lung cancer patients. Mutat. Res. 670, 74–78.
  16. Zhu X, Wang Z, He J, Wang W, Xue W, Wang Y, Zheng L, Zhu ML. Associations between CYP1A1 rs1048943 A > G and rs4646903 T > C genetic variations and colorectal cancer risk: Proof from 26 case-control studies. Oncotarget. 2016;7(32):51365-51374.
  17. Xu L, Wei H. Association between CYP1A1 2454A > G polymorphism and colorectal cancer risk: A meta-analysis. J Cancer Res Ther. 2015 Oct-Dec;11(4):760-4.
  18. Liu C, Jiang Z, Deng QX, Zhao YN. Meta-analysis of association studies of CYP1A1 genetic polymorphisms with digestive tract cancer susceptibility in Chinese. Asian Pac J Cancer Prev. 2014;15(11):4689-95.
  19. He XF, Wei W, Liu ZZ, Shen XL, Yang XB, Wang SL, Xie DL. Association between the CYP1A1 T3801C polymorphism and risk of cancer: evidence from 268 case-control studies. Gene. 2014 Jan 25;534(2):324-44.
  20. Qin J, Zhang JX, Li XP, Wu BQ, Chen GB, He XF. Association between the CYP1A1 A2455G polymorphism and risk of cancer: evidence from 272 case-control studies. Tumour Biol. 2014;35(4):3363-76.
  21. Zheng Y, Wang JJ, Sun L, Li HL. Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis. Mol Biol Rep. 2012 Apr;39(4):3533-40.
  22. Jin JQ, Hu YY, Niu YM, Yang GL, Wu YY, Leng WD, Xia LY. CYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: a meta-analysis. World J Gastroenterol. 2011 Jan 14;17(2):260-6.
  23. Swartz MK. The PRISMA statement: a guideline for systematic reviews and meta-analyses. J Pediatr Health Care. 2011;25:1–2.
  24. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560.
  25. Mantel N, HaenszelW. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-748.
  26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
  27. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088–101.
  28. Egger M, Smith DG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997;315:629–34.
  29. Dual S, Tweedie R. A nonparametric “trim and fill” method of accounting for publication bias in meta-analysis. J Am Stat Assoc 2000;95:89–98.
  30. Wakefield J. A Bayesian measure of the probability of false discovery in genetic epidemiology studies. Am J Hum Genet. 2007 Aug;81(2):208-27.
  31. Attia J, Thakkinstian A, D’Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol. 2003;56:297–303.